JUNIPER: A Randomized Phase 3 Study of Abemaciclib (LY2835219) plus Best Supportive Care versus Erlotinib plus Best Supportive Care in Patients with Stage IV NSCLC with a Detectable KRAS Mutation Who Have Progressed After Platinum-Based Chemotherapy (JPBK)

Supported projects > Other Supported Projects · 2016

Authors: Tuncay GÖKSEL

2016-2018, Other Supported Projects, R & D Project, Completed

View details